Estrogen regulation of cell cycle progression in breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 65, Issue 1-6, 1998, Pages 169-174

  Prall, Owen W J ^a   Rogan, Eileen M ^a   Sutherland, Robert L ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; ESTRADIOL; ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYC PROTEIN; NOCODAZOLE;

BREAST CANCER; CELL CYCLE; CONFERENCE PAPER; DRUG MECHANISM; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOGENESIS;

ANIMALS; CDC2-CDC28 KINASES; CELL CYCLE; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY NEOPLASMS, EXPERIMENTAL; MITOGENS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 0032052260     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(98)00021-1     Document Type: Conference Paper

References (51)

1. Lippman M., Bolan G., Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long term tissue culture. Cancer Res. 36:1976;4595-4601.
2. 1 phase population. J. Cell. Biochem. 34:1987;213-225.
3. Sutherland R. L., Reddel R. R., Green M. D. Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antioestrogens. Eur. J. Cancer Clin. Oncol. 19:1983;307-318.
4. Weinberg R. A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
5. Riley D. J., Lee E. Y.-H. P., Lee W.-H. The retinoblastoma protein: More than a tumor suppressor. Annu. Rev. Cell Biol. 10:1994;1-29.
6. 1 cyclins. Cell. 73:1993;1059-1065.
7. Morgan D. O. Principles of CDK regulation. Nature (London). 374:1995;131-134.
8. 1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
9. Henriksson M., Luscher B. Proteins of the Myc network: Essential regulators of cell growth and differentiation. Adv. Cancer Res. 68:1996;109-182.
10. 1 cyclin-cdk complexes. EMBO J. 14:1995;4814-4826.
11. Rudolph B., Saffrich R., Zwicker J., Henglein B., Muller R., Ansorge W., Eilers M. Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J. 15:1996;3065-3076.
12. Perez-Roger I., Solomon D. L., Sewing A., Land H. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene. 14:1997;2373-2381.
13. Sutherland R. L., Hall R. E., Taylor I. W. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. Cancer Res. 43:1983;3998-4006.
14. 1 phase. Cancer Res. 43:1983;3583-3585.
15. Taylor I. W., Hodson P. J., Green M. D., Sutherland R. L. Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells. Cancer Res. 43:1983;4007-4010.
16. Jordan V. C., Murphy C. S. Endocrine pharmacology of antioestrogens as antitumour agents. Endocr. Rev. 11:1990;578-610.
17. Reddel R. R., Murphy L. C., Sutherland R. L. Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen. Cancer Res. 44:1984;2398-2405.
18. van der Burg B., Rutteman G. R., Blankenstein M. A., de Laat S. W., van Zoelen E. J. J. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: Synergistic action of insulin and estrogen. J. Cell. Physiol. 134:1988;101-108.
19. Foster J. S., Wimalasena J. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Mol. Endocrinol. 10:1996;488-498.
20. 1-arrested human breast cancer cells. Oncogene. 12:1996;2315-2324.
21. 1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J. Biol. Chem. 272:1997;10882-10894.
22. Planas-Silva M. D., Weinberg R. A. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Mol. Cell. Biol. 17:1997;4059-4069.
23. Thomas T., Thomas T. J. Regulation of cyclin B1 by estradiol and polyamines in MCF-7 breast cancer cells. Cancer Res. 54:1994;1077-1084.
24. Wilcken N. R. C., Prall O. W. J., Musgrove E. A., Sutherland R. L. Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens. Clin. Cancer Res. 3:1997;849-854.
25. Dubik D., Dembinski T. C., Shiu R. P. C. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Res. 47:1987;6517-6521.
26. Amati B., Land H. Myc-Max-Mad: A transcription factor network controlling cell cycle progression, differentiation and death. Current Opinion in Genetics and Development. 4:1994;102-108.
27. Dubik D., Shiu R. P. Mechanism of estrogen activation of c-myc oncogene expression. Oncogene. 7:1992;1587-1594.
28. Murphy L. J., Murphy L. C., Friesen H. G. Estrogen induction of N-myc and c-myc proto-oncogene expression in the rat uterus. Endocrinology. 120:1987;1882-1888.
29. Dubik D., Shiu R. P. C. Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. J. Biol. Chem. 263:1988;12705-12708.
30. Watson P. H., Pon R. T., Shiu R. P. C. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. Cancer Res. 51:1991;3996-4000.
31. Stewart T. A., Pattengale P. K., Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell. 38:1984;627-637.
32. Sinn E., Muller W., Pattengale P., Tepler I., Wallace R., Leder P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo. Cell. 49:1987;465-475.
33. Edwards P. A. W., Ward J. L., Bradbury J. M. Alteration of morphogenesis by the v-myc oncogene in transplants of mammary gland. Oncogene. 2:1988;407-412.
34. Vlach J., Hennecke S., Alevizopoulos K., Conti D., Amati B. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J. 15:1996;6595-6604.
35. Watts C. K. W., Brady A., Sarcevic B., deFazio A., Musgrove E. A., Sutherland R. L. Antiestrogen inhibition of cell cycle progression in breast cancer cells is associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation. Mol. Endocrinol. 9:1995;1804-1813.
36. Hurd C., Khattree N., Dinda S., Alban P., Moudgil V. K. Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells. Oncogene. 15:1997;991-995.
37. 1 phase of the cell cycle. Cell. 65:1991;701-713.
38. Sicinski P., Donaher J. L., Parker S. B., Li T., Fazeli A., Gardner H., Haslam S. Z., Bronson R. T., Elledge S. J., Weinberg R. A. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell. 82:1995;621-630.
39. Fantl V., Stamp G., Andrews A., Rosewell I., Dickson C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9:1995;2364-2372.
40. Musgrove E. A., Hamilton J. A., Lee C. S. L., Sweeney K. J. E., Watts C. K. W., Sutherland R. L. Growth factor, steroid and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol. Cell. Biol. 13:1993;3577-3587.
41. 1 checkpoint. Mol. Cell. Biol. 16:1996;6917-6925.
42. 1 in mammalian fibroblasts. Science. 259:1993;1908-1912.
43. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1994;1669-1679.
44. 1-to-S phase transition. Mol. Cell. Biol. 15:1995;2612-2624.
45. 1 phase of the human cell cycle. Science. 257:1992;1689-1694.
46. Prall, O. W. J., Rogan, E. M., Musgrove, E. A., Watts, C. K. W., Sutherland, R. L. Mol. Cell. Biol. (1998) in press.
47. Solomon D. L., Philipp A., Land H., Eilers M. Expression of cyclin D1 mRNA is not upregulated by Myc in rat fibroblasts. Oncogene. 11:1995;1893-1897.
48. Daksis J. I., Lu R. Y., Facchini L. M., Marhin W. W., Penn L. J. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene. 9:1994;3635-3645.
49. Jansen-Durr P., Meichle A., Steiner P., Pagano M., Finke K., Botz J., Wessbecher J., Draetta G., Eilers M. Differential modulation of cyclin gene expression by Myc. Proc. Natl. Acad. Sci. U.S.A. 90:1993;3685-3689.
50. Zhu L., Harlow E., Dynlacht B. D. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev. 9:1995;1740-1752.
51. Shiyanov P., Bagchi S., Adami G., Kokontis J., Hay N., Arroyo M., Morozov A., Raychaudhuri P. p21 disrupts the interaction between cdk2 and the E2F-p130 complex. Mol. Cell. Biol. 16:1996;737-744.